Edwards Lifesciences

EW

NASDAQ·Health Care

Market Cap
-
P/E Ratio
-
Dividend Yield
-

Company Overview

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; the Dominican Republic; Puerto Rico; and Singapore; and is building a new facility completed in 2021 in Limerick, Ireland.

Industry
Health Care Equipment

Financial Summary

Revenue (TTM)
$4.46B
Net Income (TTM)
$1.52B
Total Assets
$9.36B
Total Debt
$600.00M
Total Equity
$6.65B
Market Cap
-

Valuation Metrics

P/E Ratio
-
P/B Ratio
-
Profit Margin
34.09%
ROE
22.89%
ROA
16.25%
Dividend Yield
-